<Back to Articles page.>
unpublished article by SGA, M.D. April 1998
Following is a Summary by Chris Duffield.
The original article resides on Dr. SGA's website.
Insulin potentiation therapy (IPT) in Mexico goes still further, using just low-dose chemotherapy as neoadjuvant (before or without surgery) treatment of breast cancer. In one anecdotal case (Eur. J. Cancer & Clin. Oncol. 26(11/12):1262-1263, 1990), a woman experienced complete remission after 8 treatments in 6 weeks, with no side effects. Afterwards she had a normal pregnancy and delivery, followed by normal breast feeding.
Despite the promising results of Dr. Jacquillat and the doctors in Mexico, there is no completely breast preserving protocol currently under study. Except by request of the patient, the only way a novel treatment may be tried is after failure of standard treatment, which begins with surgery, which in the case of lumpectomy means the removal of a minimum of one-fourth of the breast.
A "Safe-Trial" period is proposed, in which a patient would undergo IPT treatments for one month before surgery is scheduled. After the third week, the degree of progress would be assessed. With good progress, the patient would continue to receive IPT. Without it, she would go on to standard therapy. Ideally, the patient would also be given counseling on nutrition, immune support, and mind-body techniques, both before and after this decision point. There would be no survival risk involved in holding off on standard therapy for one month, as this often happens anyway before surgery is scheduled.
This "Safe-Trial" proposal balances scientific concerns with compassion and human values.